Quest sells unit to Danaher

Investor's Business Daily

Danaher's (DHR) blood-test division Radiometer Medical agreed to pay $300 mil for the HemoCue unit of Quest Diagnostics (DGX). Quest originally announced its plans to sell HemoCue, which makes blood-testing systems used in doctors' offices, back in mid-Jan. in its ongoing strategy to get out of diagnostic products and focus more on diagnostic information services. Danaher's Radiometer Medical also specializes in blood analysis. Quest shares fell 0.2% to 55.64. Danaher shares fell 2.6% to 59.89.

View Comments